Pages that link to "Q40218384"
Jump to navigation
Jump to search
The following pages link to A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. (Q40218384):
Displaying 23 items.
- Depo-provera in adolescents: Effects of early second injection or prior oral contraception (Q28296633) (← links)
- The use of long-acting contraceptives in adolescents (Q33736730) (← links)
- Injectable contraception. New and existing options (Q33926165) (← links)
- Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety (Q34227698) (← links)
- Depo-Provera--ethical issues in its testing and distribution (Q34379406) (← links)
- Premenopausal women and low bone density (Q35607188) (← links)
- Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive (Q36654106) (← links)
- Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial (Q36973336) (← links)
- Oxidative stress, lipid profile and liver functions in average Egyptian long term depo medroxy progesterone acetate (DMPA) users. (Q38997436) (← links)
- Sexuality, fertility and contraception in disability (Q40114055) (← links)
- Long Acting Contraceptives Present Status (Q40115006) (← links)
- The use of norplant and depo provera in adolescents (Q40475686) (← links)
- Contraceptive choice for women with 'risk factors'. (Q40901274) (← links)
- Iron supplementation and malaria (Q47973024) (← links)
- Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa (Q50285633) (← links)
- Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism (Q67902787) (← links)
- Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate (Q72521859) (← links)
- Acceptability of depo-provera (Q72571858) (← links)
- Return of ovulation following a single injection of depo-medroxyprogesterone acetate: A pharmacokinetic and pharmacodynamic study (Q72817695) (← links)
- Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different doses (Q72819893) (← links)
- The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera (Q73054855) (← links)
- Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem® (Q73503961) (← links)
- Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus (Q74296173) (← links)